Farther Finance Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Farther Finance Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.4K	Buy	1,136 +887	+356%	+$11.9K	﹤0.01%	3876
2025 Q4	$3.14K	Buy	249 +100	+67%	+$1.14K	﹤0.01%	4518
2025 Q3	$1.49K	Buy	149 +139	+1,390%	+$1.25K	﹤0.01%	4242
2025 Q2	$81	Sell	10 -2	-17%	-$15	﹤0.01%	4328
2025 Q1	$99	Hold	12	–	–	﹤0.01%	4062
2024 Q4	$95	Buy	12 +2	+20%	+$17	﹤0.01%	3790
2024 Q3	$83	Buy	10 +1	+11%	+$8	﹤0.01%	3810
2024 Q2	$58	Hold	9	–	–	﹤0.01%	3675
2024 Q1	$54	Hold	9	–	–	﹤0.01%	3459
2023 Q4	$55	Buy	+9	New	+$40	﹤0.01%	3368

Other funds holding AMRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return